[1]陈云照 张瑞剑 张义松 韩志桐 王 忠.RSF-1在胶质瘤组织中的表达及其与病人预后的关系[J].中国临床神经外科杂志,2020,(09):603-606.[doi:10.13798/j.issn.1009-153X.2020.09.009]
 CHEN Yun-zhao,ZHANG Rui-jian,ZHANG Yi-song,et al.Expression of RSF-1 in glioma tissues and its relationship with prognosis of patients with glioma[J].,2020,(09):603-606.[doi:10.13798/j.issn.1009-153X.2020.09.009]
点击复制

RSF-1在胶质瘤组织中的表达及其与病人预后的关系()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年09期
页码:
603-606
栏目:
论著
出版日期:
2020-09-20

文章信息/Info

Title:
Expression of RSF-1 in glioma tissues and its relationship with prognosis of patients with glioma
文章编号:
1009-153X(2020)09-0603-04
作者:
陈云照 张瑞剑 张义松 韩志桐 王 忠
010017 呼和浩特,内蒙古自治区人民医院神经外科( 陈云照、张瑞剑、张义松、韩志桐、王 忠)
Author(s):
CHEN Yun-zhao ZHANG Rui-jian ZHANG Yi-song HAN Zhi-tong WANG Zhong.
Department of Neurosurgery, Inner Mongolia People's Hospital, Hohhot 010017, China
关键词:
胶质瘤染色质重塑因子1基因表达生存预后
Keywords:
Glioma Remodeling and spacing factor 1 Gene expression Prognosis
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2020.09.009
文献标志码:
R 739.41; Q 786
摘要:
目的 探讨染色质重塑因子1(RSF-1)在人脑胶质瘤中的表达及其与病人预后的关系。方法 采用免疫组织化学染色法和免疫印迹法检测2010年1月~2013年4月手术切除的121例胶质瘤组织和2017年6月~2018年9月颅脑损伤内减压术中切取的50例正常脑组织RSF-1的表达水平。胶质瘤病人随访时间截止至2019年4月。多因素Cox比例回归风险模型分析影响胶质瘤病人生存预后的因素。结果 免疫组化染色结果显示胶质瘤组织RSF-1高表达率(66.12%,80/121)明显高于正常脑组织(0%;P<0.001)。免疫印迹法检测结果显示,胶质瘤组织RSF-1蛋白表达水平明显高于正常脑组织(P<0.05),而且,随胶质瘤级别增高,RSF-1蛋白表达水平明显增高(P<0.05)。多因素Cox比例回归风险模型分析结果显示,术前KPS评分<80分、WHO分级为Ⅲ~Ⅳ级、术后未化疗和RSF-1高表达是胶质瘤病人总生存期和无进展生存期缩短的独立影响因素(P<0.05)。RSF-1高表达病人总体生存期[中位数(M):13个月;四分位间距(IQR):11~26个月]较低表达者(M:26个月;IQR:20~36个月)明显缩短(P<0.05)。 RSF-1高表达病人无进展生存期(M:11个月;IQR:7~23个月)较低表达者(M:21个月;IQR:16~28个月)明显缩短(P<0.05)。结论 RSF-1高表达可能预示着胶质瘤病人的不良生存预后
Abstract:
Objective To investigate the expression of chromatin remodeling factor 1 (remodeling and spacing factor 1) in glioma tissues and its relationship with the prognosis of patients with glioma. Methods The expression levels of RSF-1 in 121 glioma tissues which were obtained from glioma patients underwent micorsurgery from January 2010 to April 2013 and in 50 normal brain tissues which were obtained from patients with traumatic brain injury underwent decompression from June 2017 to September 2018 were detected by immunohistochemical staining and western blotting. The follow-up time of glioma patients was up to April 2019. Cox proportional hazard model analysis was used to analyze the risk factors for the survival prognosis of glioma patients. Results The high expression rate of RSF-1 in glioma tissues (66.12%, 80/121) was significantly higher than that (0%) in normal brain tissues (P<0.001) according to the results of immunohistochemical staining. The results of western blotting showed that the expression level of RSF-1 protein in glioma tissues was significantly higher than that in normal brain tissues (P<0.05), and the expression level of RSF-1 protein increased significantly as the grade of glioma increased (P<0.05). The multivariate Cox proportional regression risk model analysis showed that the preoperative KPS score <80 points, WHO grade Ⅲ~Ⅳ, no postoperative chemotherapy and high RSF-1 expression were the risk factors for the shortening of overall survival time and progression-free survival time of glioma patients (P<0.05). The median overall survival time and progression-free survival time were significantly shorter in patients with high RSF-1 expression than those with low RSF-1 expression (P<0.05). Conclusion The high expression of RSF-1 may predict the poor survival prognosis of glioma patients

参考文献/References:

[1] Helfricht A, van Attikum H. Remodeling and spacing factor 1 (RSF1): a rising star in DNA repair [J]. Epigenomics, 2014, 6(3): 261-265.
[2] Tian J, Kong E, Wang X, et al. RSF-1 siRNA enhances tumor radiosensitivity in cervical cancer via enhanced DNA damage, cell cycle redistribution, and promotion of apopto- sis [J]. Onco Targets Ther, 2020, 13: 3061-3071.
[3] Zhao XC, An P, Wu XY, et al. Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemo- resistance through its interaction with Rsf-1 [J]. Tumour Biol, 2016, 37(6): 7203-7212.
[4] 葛盛徐,盛莉莉,徐善水,等. 12-LOX 在神经胶质瘤中的 表达及临床意义[J]. 中国肿瘤临床,2015,42(19):953- 956.
[5] Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassi- fication to novel treatment options [J]. Semin Cancer Biol, 2018, 51: 50-58.
[6] Zhang X, Xue D, Hao F, et al. Remodeling and spacing factor 1 overexpression is associated with poor prognosis in renal cell carcinoma [J]. Oncol Lett, 2018, 15(3): 3852- 3857.
[7] Liu Y, Gai J, Fu L, et al. Effects of RSF-1 on proliferation and apoptosis of breast cancer cells [J]. Oncol Lett, 2018, 16 (4): 4279-4284.
[8] Hoflmayer D, Hamuda M, Schroeder C, et al. High RSF1 protein expression is an independent prognostic feature in prostate cancer [J]. Acta Oncol, 2020, 59(3): 268-273.
[9] Chen X, Sun X, Guan J, et al. Rsf-1 influences the sensiti- vity of non-small cell lung cancer to paclitaxel by regula- ting NF-κB pathway and its downstream proteins [J]. Cell Physiol Biochem, 2017, 44(6): 2322-2336.
[10] Li Q, Dong Q, Wang E. Rsf-1 is overexpressed in non- small cell lung cancers and regulates cyclinD1 expression and ERK activity [J]. Biochem Biophys Res Commun, 2012, 420(1): 6-10.
[11] Liu F, Tai Y, Ma J. LncRNA NEAT1/let-7a-5p axis regu- lates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway [J]. Cancer Biol Ther, 2018, 19(6): 534-542.
[12] 周建华,胡 涛,陈 宇,等. lncRNA NEAT1在人脑胶质 瘤的表达变化及其与病人预后的关系[J]. 中国临床神经 外科杂志,2019,24(3):148-150,161.
[13] 白庆岭,胡长伟,彭营影,等. 脑胶质瘤预后影响因素分析 [J]. 临床误诊误治,2018,36(7):97-100.
[14] 沈 帅,杨连赫,于承仟,等. RSF-1与肿瘤关系的研究进 展及相关作用机制[J]. 现代肿瘤医学,2016,24(16): 2660-2663.

相似文献/References:

[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
 CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(09):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
 XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(09):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
 LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(09):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
 YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(09):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
 HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(09):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
 DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(09):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
 PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(09):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
 FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(09):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
(2020-07-02收稿,2020-07-23修回)基金项目:内蒙古自治区自然科学基金(2015MS0840) 通讯作者:张瑞剑,E-mail:hfdghr123@126.com
更新日期/Last Update: 2020-09-20